Assignee
RENEO PHARMACEUTICALS INC
US·3 granted patents·6 pending applications·4 citations·filing 2020–2023
Top patents by PatentIndex Score
9 records- 0188US11267795B2Crystalline PPAR-delta agonistRENEO PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·4 cites·16 claims
- 0270US11931365B2Use of PPAR-delta agonists in the treatment of diseaseRENEO PHARMACEUTICALS INC·Filed 2023·Granted Mar 19, 2024·0 cites·14 claims
- 0370US2024002356A1Crystalline ppar-delta agonistRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0468US2024016809A1Use of ppar-delta agonists in the treatment of diseaseRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0567US11713301B2Crystalline PPARδ agonistRENEO PHARMACEUTICALS INC·Filed 2022·Granted Aug 1, 2023·0 cites·19 claims
- 0654US2023416210A1Methods of making a ppar-delta agonistRENEO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0746US2022370467A1Using of a ppar-delta agonist in the treatment of kidney diseaseRENEO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0844US2022117972A1Use of ppar-delta agonists in the treatment of mitochondrial myopathyRENEO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0944US2022023306A1Use of a ppar-delta agonist in the treatment of fatty acid oxidation disorders (faod)RENEO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →